Results 101 to 110 of about 18,591,271 (238)
Synthetic Cannabinoid Receptor Agonists (SCRAs)
Synthetic cannabinoid receptor agonists (SCRAs), originally developed for biomedical research purposes, are now one of the biggest classes of new psychoactive substances (NPS).
Pfeifer, Philippe +1 more
core +1 more source
International Journal of Eating Disorders, EarlyView.ABSTRACT Objective This study aimed to evaluate the feasibility of implementing 10‐session group cognitive behavioural therapy (CBT‐Tg) in routine outpatient eating disorder care and to descriptively examine outcomes of CBT‐Tg and individual CBT‐T (CBT‐Ti). Method Using a naturalistic, non‐randomised, mixed‐methods design, this implementation study was
Laura Dixon +13 more
wiley +1 more source
In Vivo Analysis of New Psychoactive Substances： Nitazenes
Fayixue ZazhiNitazenes are a class of synthetic opioids that have recently emerged in the illegal drug market. They are characterized by high potency and a narrow therapeutic window.
GAO Guo-qing +4 more
doaj +1 more source
Enhancing quality of mental health service for veterans with seizures
Epilepsia, EarlyView.Abstract Psychiatric disorders are commonly identified in people with seizures (PWS). Comorbid mood, anxiety, and trauma‐ and stressor‐related disorders are highly prevalent and not consistently recognized or treated promptly. Veterans with seizures are particularly vulnerable to neuropsychiatric comorbidities, including a higher prevalence of ...
Maria Raquel Lopez +6 more
wiley +1 more source
Novel psychoactive substances: synthetic cannabinoids - best practice treatment approaches.
, 2017 The use of new psychoactive substances [NPS] in prisons has been recognised as an increasing problem for several years. Successive Chief Inspectors of Prisons and the Prisons and Probation Ombudsman in the UK have drawn attention to the impact on prisons,
Ryan, George
core
Epilepsia, EarlyView.Abstract Objective Levetiracetam (LEV) is an antiseizure medication approved for focal and generalized epilepsy. Despite its efficacy, neuropsychiatric adverse effects (NP‐AEs) may lead to treatment discontinuation. Quantitative electroencephalographic (qEEG) graph‐theoretical analysis has emerged as a valuable tool for identifying neurophysiological ...
Marco Sferruzzi +10 more
wiley +1 more source
Epilepsia Open, EarlyView.Abstract Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and represents a major unmet clinical need. While traditional hypotheses of pharmacoresistance have focused on alterations in drug targets, efflux transporter overexpression, and intrinsic disease severity, the gut microbiome has recently emerged as a ...
Khaled Zammar +4 more
wiley +1 more source
Sleep Health in Bulimia Nervosa: A Systematic Review
European Eating Disorders Review, EarlyView.ABSTRACT Objective Research on sleep in bulimia nervosa (BN) is methodologically varied and yields inconsistent findings. This review synthesised BN‐sleep studies and examined whether comorbid mood disorders contribute to sleep disturbance. Method PsycINFO, Medline (Ovid), and Scopus were searched for English or French quantitative studies comparing ...
Samantha Kenny +4 more
wiley +1 more source
Novel Psychoactive Substances (NPS) profile in South Gloucestershire [PDF]
, 2014 Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause similar reactions to those produced by taking conventional drugs. The report estimates the prevalence of NPS use across South Gloucestershire.
Ismail, Nasrul
core +1 more source
Scientific ReportsIt is well-recognized that individuals with alcohol-related disorders often use other psychoactive substances; however, systematic research on this topic remains limited.
Piotr Engelgardt +4 more
doaj +1 more source